Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Yusuf Dölen, Michael Valente, Oya Tagit, Eliezer Jäger, Eric A. W. Van Dinther, N. Koen van Riessen, Martin Hruby, Uzi Gileadi, Vincenzo Cerundolo, Carl G. Figdor

Journal title: OncoImmunology

Journal number: 9/1

Journal publisher: OncoImmunology

Published year: 2020

Published pages: 1738813

DOI identifier: 10.1080/2162402x.2020.1738813

ISSN: 2162-402X